fbpx Skip to main content

In this interview, Dr. Martinez-Diaz gives advice to dermatologists with patients who have vitiligo. He also explains the importance of keeping the most up-to-date with the news and the latest technology.

MD Newsline: What advice do you have for dermatologists?

Dr. Martinez-Diaz
: I would say that definitely keeping the most up-to-date with the new news and latest technology and also medications that are being improved. Fortunately, in the last year, the treatment of vitiligo has been expanded to increase to include a new set of medications called JAK2 so now we have some topical treatments that are quite innovative and available for patients. There’s also potential for an oral medication to be approved for the treatment of vitiligo, so there’s definitely a lot of exciting things happening that are coming to the pipeline and it’s in the best interest of dermatologists caring for patients with vitiligo to be kept up to date.

You May Also Like::  Dr. Victoria Barbosa: Central Centrifugal Cicatricial Alopecia (CCCA)

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More